The document is an intimation of a scheduled Analyst/Institutional Investor Meeting, filed as a regulatory disclosure with BSE and NSE.
The event is participation in the Morgan Stanley India Investment Forum 2026.
The meeting is scheduled for June 3, 2026.
The venue for the meeting is Mumbai.
The type of meeting will be One-to-One / Group Meeting.
The disclosure is made in compliance with Regulation 30, Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.
The letter is digitally signed by Parvatheesam Kanchinadham, Company Secretary and Chief Legal Officer.
The company reference number for the filing is SEC/386/2026-27.
Additional Notes Section
The document is a formal letter of intimation addressed to the listing departments of BSE Limited and the National Stock Exchange of India Limited.
A note clarifies that the schedule is subject to change due to exigencies on the part of the Fund/Broking House, Analyst, or the Company.
No financial highlights, guidance, presentation details, or management participants are disclosed in this announcement.
The document contains standard compliance language but does not explicitly state whether unpublished price sensitive information (UPSI) will be shared.
